Topics in Clinical Pharmacology: Imipenem, A New Broad Spectrum Antibiotic
- 1 October 1988
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 296 (4) , 289-291
- https://doi.org/10.1016/s0002-9629(15)40868-7
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 1986
- Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infectionsAntimicrobial Agents and Chemotherapy, 1986
- Antibacterial Activity of Imipenem: The First Thienamycin AntibioticClinical Infectious Diseases, 1985
- Carbapenems: Special properties contributing to their activityThe American Journal of Medicine, 1985
- Review of the in vitro spectrum of activity of imipenemThe American Journal of Medicine, 1985
- Pneumonia treated with imipenem/cilastatinThe American Journal of Medicine, 1985
- Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1985
- Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditisAntimicrobial Agents and Chemotherapy, 1984
- Susceptibility of anaerobic bacteria to imipenemJournal of Antimicrobial Chemotherapy, 1983
- Activity of imipenem on aerobic bacteriaJournal of Antimicrobial Chemotherapy, 1983